Gisela Soboll Hussey

Dr. Gisela Soboll Hussey

Michigan State University
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Veterinary Clinics of North America: Equine Practice
Verified
Journal Article
Closed access
NPNicola Pusterla
Nicola Pusterla
Gisela Soboll HusseyGisela Soboll Hussey
Gisela Soboll Hussey

7 February 2011 in Veterinary Research
Verified
Journal Article
Open access
PDF file
Gisela Soboll HusseyGisela Soboll Hussey
Gisela Soboll Hussey
SHStephen B Hussey
Stephen B Hussey
BWBettina Wagner
Bettina Wagner
DHDavid W Horohov
David W Horohov
GWGerlinde Van de Walle
Gerlinde Van de Walle
DLDavid P Lunn
David P Lunn
Equine herpesvirus-1 (EHV-1) infection remains a significant problem despite the widespread use of vaccines. The inability to generate a protective immune response to EHV-1 vaccination or infection is thought to be due to immunomodulatory properties of the virus, and the ORF1 and ORF2 gene products have been hypothesized as potential candidates with immunoregulatory properties. A pony infection study was performed to define immune responses to EHV-1, and to determine if an EHV-1 ORF1/2 deletion mutant (ΔORF1/2) would have different disease and immunoregulatory effects compared to wild type EHV-1 (WT). Infection with either virus led to cytokine responses that coincided with the course of clinical disease, particularly the biphasic pyrexia, which correlates with respiratory disease and viremia, respectively. Similarly, both viruses caused suppression of proliferative T-cell responses on day 7 post infection (pi). The ΔORF1/ORF2 virus caused significantly shorter primary pyrexia and significantly reduced nasal shedding, and an attenuated decrease in PBMC IL-8 as well as increased Tbet responses compared to WT-infected ponies. In conclusion, our findings are (i) that infection of ponies with EHV-1 leads to modulation of immune responses, which are correlated with disease pathogenesis, and (ii) that the ORF1/2 genes are of importance for disease outcome and modulation of cytokine responses.

1 January 2013 in Veterinary Research
Verified
Journal Article
Open access
PDF file
Gisela Soboll HusseyGisela Soboll Hussey
Gisela Soboll Hussey
LGLutz Steffen Goehring
Lutz Steffen Goehring
DLDavid P Lunn
David P Lunn
SHStephen B Hussey
Stephen B Hussey
THTeng Huang
Teng Huang
JSJosh Slater
Josh Slater
Equine herpesvirus myeloencephalitis (EHM) remains one of the most devastating manifestations of equine herpesvirus type 1 (EHV-1) infection but our understanding of its pathogenesis remains rudimentary, partly because of a lack of adequate experimental models. EHV-1 infection of the ocular vasculature may offer an alternative model as EHV-1-induced chorioretinopathy appears to occur in a significant number of horses, and the pathogenesis of EHM and ocular EHV-1 may be similar. To investigate the potential of ocular EHV-1 as a model for EHM, and to determine the frequency of ocular EHV-1, our goal was to study: (1) Dissemination of virus following acute infection, (2) Development and frequency of ocular lesions following infection, and (3) Utility of a GFP-expressing virus for localization of the virus in vivo. Viral antigen could be detected following acute infection in ocular tissues and the central nervous system (experiment 1). Furthermore, EHV-1 infection resulted in multifocal choroidal lesions in 90% (experiment 2) and 50% (experiment 3) of experimentally infected horses, however ocular lesions did not appear in vivo until between 3 weeks and 3 months post-infection. Taken together, the timing of the appearance of lesions and their ophthalmoscopic features suggest that their pathogenesis may involve ischemic injury to the chorioretina following viremic delivery of virus to the eye, mirroring the vascular events that result in EHM. In summary, we show that the frequency of ocular EHV-1 is 50-90% following experimental infection making this model attractive for testing future vaccines or therapeutics in an immunologically relevant age group.

1 April 2011 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
AQAyshea M. Quintana
Ayshea M. Quintana
GLGabriele A. Landolt
Gabriele A. Landolt
KAKristina M. Annis
Kristina M. Annis
Gisela Soboll HusseyGisela Soboll Hussey
Gisela Soboll Hussey

1 May 2024 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
DLDavid P. Lunn
David P. Lunn
BBBrandy A. Burgess
Brandy A. Burgess
David DormanDavid Dorman
David Dorman
LGLutz Steffen Goehring
Lutz Steffen Goehring
PGPeggy Gross
Peggy Gross
Gisela Soboll HusseyGisela Soboll Hussey
Gisela Soboll Hussey
Equine herpesvirus-1 (EHV-1) is a highly prevalent and frequently pathogenic infection of equids. The most serious clinical consequences of infection are abortion and equine herpesvirus myeloencephalopathy (EHM). The previous consensus statement was published in 2009 and considered pathogenesis, strain variation, epidemiology, diagnostic testing, vaccination, outbreak prevention and control, and treatment. A recent survey of American College of Veterinary Internal Medicine large animal diplomates identified the need for a revision to this original consensus statement. This updated consensus statement is underpinned by 4 systematic reviews that addressed key questions concerning vaccination, pharmaceutical treatment, pathogenesis, and diagnostic testing. Evidence for successful vaccination against, or effective treatment of EHV-1 infection was limited, and improvements in experimental design and reporting of results are needed in future studies of this important disease. This consensus statement also updates the topics considered previously in 2009.

31 August 2012 in Vaccine
Verified
Journal Article
Closed access
DGDavid W. Gardiner
David W. Gardiner
DLDavid P. Lunn
David P. Lunn
LGLutz Steffen Goehring
Lutz Steffen Goehring
YCYu-Wei Chiang
Yu-Wei Chiang
CCCorey Cook
Corey Cook
Gisela Soboll HusseyGisela Soboll Hussey
Gisela Soboll Hussey